TickerFactsScreenerDevelopers

CRESCENT BIOPHARMA, INC. (CBIO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: $3.64M2013: -$10.61M2014: -$11.14M2015: -$12.78M2016: -$31.91M2017: -$33.93M2018: -$51.50M2019: -$61.39M2020: -$51.51M2021: -$63.45M2022: -$47.40M2023: -$39.28M2024: -$40.04M2025: -$152.63M-$152.63M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$152.63M-281.2%
2024-$40.04M-1.9%
2023-$39.28M+17.1%
2022-$47.40M+25.3%
2021-$63.45M-23.2%
2020-$51.51M+16.1%
2019-$61.39M-19.2%
2018-$51.50M-51.8%
2017-$33.93M-6.3%
2016-$31.91M-149.6%
2015-$12.78M-14.8%
2014-$11.14M-5.0%
2013-$10.61M-391.8%
2012$3.64M—